Nurix Therapeutics, Inc. (NRIX)

NASDAQ: NRIX · Real-Time Price · USD

19.21

+0.35 (1.86%)

At close: Jan 16, 2026, 4:00 PM EST

19.01

-0.20 (-1.04%)

After-hours: Jan 16, 2026, 7:23 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	2016 - 2019
Small Molecule and Cell Therapies	54.55M	Log In	Log In	Log In	Log In	Upgrade
Small Molecule and Cell Therapies Growth	-29.15%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	2016 - 2019
United States	54.55M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-29.15%	Log In	Log In	Log In	Log In	Upgrade